Q. Immunosuppressive therapy is effective in patients with Myasthenia gravis because it

(a) promotes the removal of antibodies
(b) stimulates the production of Ach at the synoptic cleft
(c) Decreases the production of autoantibodies that attack the acetylcholine
(d) inhibits the breakdown of acetylcholine at the NMJ